首页> 外国专利> POLYCYCLIC LACTAM DERIVATIVES FOR SENSITIZING MULTIDRUG-RESISTANT CELLS TO ANTITUMOUR AGENTS

POLYCYCLIC LACTAM DERIVATIVES FOR SENSITIZING MULTIDRUG-RESISTANT CELLS TO ANTITUMOUR AGENTS

机译:多环内酰胺衍生物,可将多药耐药细胞敏感

摘要

Staurosporin derivatives of formula (I), wherein R1 is formyl, an aliphatic hydrocarbon radical having up to 29 carbon atoms that is unsubstituted or substituted by aryl, or is an aryl radical, R2 is an aliphatic, carbocyclic, carbocyclic-aliphatic, heterocyclic or heterocyclic-aliphatic radical each having up to 29 carbon atoms that is other than C1-C5alkyl, or is a heterocyclic or heterocyclic-aliphatic radical each having up to 20 carbon atoms and up to 9 hetero atoms, or is an acyl radical having up to 30 carbon atoms that is other than benzoyl, benzyloxycarbonyl, lower alkanoyl or alpha -aminoacyl having a free or protected amino group, and R3 is hydrogen, hydroxy, lower alkoxy or oxo, are described. These derivatives can be used for avoiding or removing multidrug resistance to antitumour agents, such as vinblastine or adriamycin.
机译:式(I)的星形孢菌素衍生物,其中R 1为甲酰基,未被取代或被芳基取代的具有至多29个碳原子的脂族烃基,或为芳基,R 2为脂族,碳环,碳环脂族,杂环或每个碳原子数最多为29的除C1-C5烷基以外的杂环脂族基团,或者为每个碳原子数最多为20和最多9个杂原子的杂环或杂环脂族基团,或者为最多具有20个碳原子的酰基基团描述了除具有游离或受保护的氨基的苯甲酰基,苄氧基羰基,低级烷酰基或α-氨基酰基以外的30个碳原子,且R 3为氢,羟基,低级烷氧基或氧代。这些衍生物可用于避免或消除对长春碱或阿霉素等抗肿瘤剂的多药耐药性。

著录项

  • 公开/公告号EP0763042A1

    专利类型

  • 公开/公告日1997-03-19

    原文格式PDF

  • 申请/专利权人 CIBA-GEIGY AG;

    申请/专利号EP19950920068

  • 申请日1995-05-19

  • 分类号C07D498/22;C07H19/044;A61K31/55;A61K31/70;

  • 国家 EP

  • 入库时间 2022-08-22 03:19:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号